Blood test may reveal hidden surgery risks in drinkers

NCT ID NCT06864819

Recruiting now Knowledge-focused Sponsor: University Hospitals Cleveland Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a blood marker called phosphatidylethanol (PEth), which reflects alcohol use over the past few weeks, can predict complications after surgery. Researchers will test PEth levels in 170 adults having elective surgery at University Hospitals Cleveland Medical Center who are expected to stay in the hospital for at least three days. The goal is to see if higher PEth levels are linked to problems like confusion, lung or heart issues, infections, or longer hospital stays.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors identify patients at higher risk for post-surgery problems based on their alcohol use, leading to better care.
What could go wrong: This is an observational study, not a treatment trial. It may find no clear link between PEth levels and outcomes, or the results may not apply to all surgery patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alcohol abuse Alcohol Drinking Postoperative Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALCOHOL USE DISORDER POSTOPERATIVE COMPLICATIONS

Contacts and locations

Locations

University Hospital
RECRUITING

Cleveland, Ohio, 44106, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.